Actualités OrthoPediatrics Corporation - KIDS | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023

WARSAW, Ind., July 18, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System

WARSAW, Ind., June 27, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

Report of Proposed Sale of Securities (144)

Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF...

Current Report Filing (8-k)

0001425450FALSE00014254502023-06-142023-06-14UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549______________________FORM...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

OrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors

WARSAW, Ind., June 15, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System

WARSAW, Ind., May 04, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

Quarterly Report (10-q)

2023Q1FALSE0001425450--12-31http://www.orthopediatrics.com/20230331#AssetsNoncurrentExcludingPropertyPlantAndEquipmenthttp://fasb.org/us-gaap/2022...

OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

WARSAW, Ind., May 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

Current Report Filing (8-k)

0001425450 false 0001425450 2023-04-27 2023-04-27 iso4217:USD xbrli:shares...

OrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting

WARSAW, Ind., May 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

Proxy Statement (definitive) (def 14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 14AProxy Statement Pursuant to Section 14(a) of the...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

OrthoPediatrics Corporation (KIDS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

KIDS Actualités

OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023

OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System

Report of Proposed Sale of Securities (144)

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

OrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors

OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System

Quarterly Report (10-q)

OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

Current Report Filing (8-k)

OrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting

Proxy Statement (definitive) (def 14a)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

OrthoPediatrics Corporation (KIDS) Actualités

OrthoPediatrics Corporation (KIDS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

KIDS Actualités

OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023

OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System

Report of Proposed Sale of Securities (144)

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

OrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors

OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System

Quarterly Report (10-q)

OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

Current Report Filing (8-k)

OrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting

Proxy Statement (definitive) (def 14a)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application